MF59- and Al(OH)3-adjuvanted Staphylococcus aureus (4C-Staph) vaccines induce sustained protective humoral and cellular immune responses, with a critical role for effector CD4 T cells at low antibody titers.
Staphylococcus aureus (S.aureus) is an important opportunistic pathogen that may cause invasive life-threatening infections like sepsis and pneumonia.Due to increasing antibiotic-resistance, the development of an effective vaccine against S.aureus is needed.Although a correlate of protection against staphylococcal diseases is not yet established, s